Is BridgeBio Pharma, Inc. overvalued?

BridgeBio Pharma, Inc. (BBIO) — key valuation metrics and fundamentals.

No verdict

Price

$78.30

Fair value

—

Current P/E

—

Normal P/E

—

Market cap

$15.25B

Dividend yield

0.0%

Return on equity

26.8%

Sector

Healthcare

Fair value compares BBIO's current P/E to its own historical "normal" P/E (FAST Graphs-style). Updated 12 Nov 2026.

Related stocks